Otlertuzumab

Names

[ CAS No. ]:
1372645-37-8

[ Name ]:
Otlertuzumab

Biological Activity

[Description]:

Otlertuzumab (TRU-016) is a humanized anti-CD37 monoclonal antibody that can be used for cancer research[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Others >> Others

[Target]

CD37[1]

[In Vitro]

Otlertuzumab (TRU-016) in combination with Rituximab (HY-P9913), Rapamycin (HY-10219), or Bendamustine (HY-13567) increases cell killing of NHL cells[2]. Otlertuzumab has the ability to bind to and kill CD37+ cells[3].

[In Vivo]

Otlertuzumab (TRU-016) in combination with Bendamustine (HY-13567) displays greater anti-tumor activity than either agent alone against a follicular lymphoma tumor model in SCID mice[2]. Otlertuzumab shows significant antitumor activity in mice bearing Ramos or Daudi tumor xenografts[3].

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.